Stockreport

FDA OKs new use of Acceleron and Bristol-Myers Squibb's luspatercept [Seeking Alpha]

Acceleron Pharma Inc.  (XLRN) 
Last acceleron pharma inc. earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.acceleronpharma.com/investor-relations
PDF Acceleron Pharma (NASDAQ:XLRNBMYannounceThe FDA firstapprovedAcceleron is co-developing luspatercept with BMY unit Celgene (NASDAQ:CELGAugust 2011 agreement [Read more]